Anu R I(@anu_iris) 's Twitter Profileg
Anu R I

@anu_iris

Physician
Multi-omics
Biochemistry
Cancer Biology & Therapeutics@Harvard
#PrecisionOncology #SpaceResearch @University_of_Malta @Guardant_Health

ID:1070970089514520576

calendar_today07-12-2018 09:15:41

972 Tweets

434 Followers

482 Following

Cancer Research, Statistics and Treatment(@CRSTonline) 's Twitter Profile Photo

Our new issue is live! Looking forward to your comments and criticism. Sincere thanks to all authors, reviewers, editors and publishers for your contribution.
Read here: bit.ly/3Kf29px
Vanita Noronha, MBBS MD DM Tata Memorial Hospital

Our new issue is live! Looking forward to your comments and criticism. Sincere thanks to all authors, reviewers, editors and publishers for your contribution. Read here: bit.ly/3Kf29px @VanitaNoronha @TataMemorial #CRST #oncology #CancerResearch #MedTwitter
account_circle
Anu R I(@anu_iris) 's Twitter Profile Photo

🔥🔊Our next one is on JCO Global Oncology
💥🩺 Refrain from treating with the options listed in a molecular diagnostic report.
🤝 Molecular Tumor Board/ specialists a must ✅
bhawna sirohi Aju Mathew

🔥🔊Our next one is on @JCOGO_ASCO 💥🩺 Refrain from treating with the options listed in a molecular diagnostic report. 🤝 Molecular Tumor Board/ specialists a must ✅ @SirohiBhawna @ajumathew_ #precisiononcology #cancergenomics #cancertreatment #oncology
account_circle
Anu R I(@anu_iris) 's Twitter Profile Photo

Surge in papers from these countries concerning: writes Gemma Conroy for 'Nature'
Few researchers were found to produce 1 publication in 5 days.
Driving factors: 'Publish or Perish' rule & Monetary rewards
nature.com/articles/d4158…

Surge in papers from these countries concerning: writes Gemma Conroy for 'Nature' Few researchers were found to produce 1 publication in 5 days. Driving factors: 'Publish or Perish' rule & Monetary rewards nature.com/articles/d4158…
account_circle
Anu R I(@anu_iris) 's Twitter Profile Photo

New💥 DIVARASIB 🧬❌anti KRAS G12C💊
Ongoing Early phase clinical trials for adv/met solid tumors
Combinatorial avenues:
D+Cetuximab
D+Bev
D+SHP2 inhibitor
D+Inavolisib

New💥 DIVARASIB 🧬❌anti KRAS G12C💊 Ongoing Early phase clinical trials for adv/met solid tumors Combinatorial avenues: D+Cetuximab D+Bev D+SHP2 inhibitor D+Inavolisib #CancerResearch #precisiononcology #cancertreatment #drugdiscovery #biochemistry
account_circle
Anu R I(@anu_iris) 's Twitter Profile Photo

FDA Approves First Gene Therapies🔥 to Treat Patients with Sickle Cell Disease🧬🧫
👫 >12 yrs
💥 Casgevy /Cas9 based
💥 Lyfgenia modification based fda.gov/news-events/pr…

FDA Approves First Gene Therapies🔥 to Treat Patients with Sickle Cell Disease🧬🧫 👫 >12 yrs 💥 Casgevy #CRISPR/Cas9 based 💥 Lyfgenia #stemcell modification based fda.gov/news-events/pr… #GeneTherapy #SickleCell #molecularbiology #GeneEditing #biochemistry
account_circle